Literature DB >> 9298375

Diagnostic tests for Helicobacter pylori infection.

A F Cutler1.   

Abstract

The two major catagories of diagnostic methods for Helicobacter pylori are invasive tests, or those that require endoscopy, and noninvasive, or nonendoscopic, tests. Diagnostic tests that use endoscopy include rapid urease tests, histology, and culture. Tests for which esophagogastroduodenoscopy is not necessary include various methods of antibody detection and carbon-labeled urea breath tests. Most tests are accurate, although none works perfectly and no gold standard for diagnosis exists. This article reviews the diagnostic methods available to establish H. pylori infection status and identifies some common mistakes made in testing. The costs associated with H. pylori diagnosis are evaluated and some cost-effective approaches to testing are suggested. Finally, the article offers some guidelines on choosing the appropriate diagnostic test in different clinical situations to determine the H. pylori infection status.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298375

Source DB:  PubMed          Journal:  Gastroenterologist        ISSN: 1065-2477


  3 in total

1.  Accuracy of Helicobacter pylori serology in two peptic ulcer populations and in healthy controls.

Authors:  Rolv-Ole Lindsetmo; Roar Johnsen; Tor Jac Eide; Tore Gutteberg; Hanne Haukland Husum; Arthur Revhaug
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

2.  Helicobacter pylori rescue treatment with vonoprazan, metronidazole, and sitafloxacin in the presence of penicillin allergy.

Authors:  Soichiro Sue; Tomohiko Sasaki; Hiroaki Kaneko; Kuniyasu Irie; Masaaki Kondo; Shin Maeda
Journal:  JGH Open       Date:  2021-01-23

3.  A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication.

Authors:  Hiroki Osumi; Junko Fujisaki; Takanori Suganuma; Yusuke Horiuchi; Masami Omae; Toshiyuki Yoshio; Akiyoshi Ishiyama; Tomohiro Tsuchida; Kazumasa Miki
Journal:  PLoS One       Date:  2017-08-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.